Platform Specialty Products (PAH) Is Strong On High Volume Today
Trade-Ideas LLC identified
(
) as a strong on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Platform Specialty Products as such a stock due to the following factors:
- PAH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $83.4 million.
- PAH has traded 487,861 shares today.
- PAH is trading at 3.49 times the normal volume for the stock at this time of day.
- PAH is trading at a new high 5.05% above yesterday's close.
'Strong on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as M&A events, material stock news, analyst upgrades, insider buying, buying from 'superinvestors,' or that hedge funds and momentum traders are piling into a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize. In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PAH with the Ticky from Trade-Ideas. See the FREE profile for PAH NOW at Trade-Ideas
More details on PAH:
Platform Specialty Products Corporation produces and sells specialty chemical products in the Americas, Asia, and Europe. Currently there is 1 analyst that rates Platform Specialty Products a buy, no analysts rate it a sell, and 2 rate it a hold.
The average volume for Platform Specialty Products has been 3.9 million shares per day over the past 30 days. Platform Specialty has a market cap of $2.3 billion and is part of the basic materials sector and chemicals industry. Shares are down 47.2% year-to-date as of the close of trading on Tuesday.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Analysis:
rates Platform Specialty Products as a
. Among the areas we feel are negative, one of the most important has been generally deteriorating net income.
Highlights from the ratings report include:
- The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Chemicals industry. The net income has significantly decreased by 3136.1% when compared to the same quarter one year ago, falling from -$0.38 million to -$12.20 million.
- This stock's share value has moved by only 57.94% over the past year. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
- PLATFORM SPECIALTY PRODUCTS's earnings have gone downhill when comparing its most recently reported quarter with the same quarter a year earlier. This year, the market expects an improvement in earnings ($0.75 versus -$1.58).
- The gross profit margin for PLATFORM SPECIALTY PRODUCTS is rather high; currently it is at 52.84%. Regardless of PAH's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, PAH's net profit margin of -1.80% significantly underperformed when compared to the industry average.
- Even though the current debt-to-equity ratio is 1.05, it is still below the industry average, suggesting that this level of debt is acceptable within the Chemicals industry. Despite the fact that PAH's debt-to-equity ratio is mixed in its results, the company's quick ratio of 2.01 is high and demonstrates strong liquidity.
- You can view the full Platform Specialty Products Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.